Recursion Secures $1.6 Million NIH Phase 2 SBIR Grant to Identify Therapeutic Candidates for…
Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover and…
Artificial Intelligence | News | Insights | AiThority